Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients
1 other identifier
observational
161,876
1 country
1
Brief Summary
Early prediction of acute kidney injury (AKI) may provide a crucial opportunity for AKI prevention. To date, no prediction model targeting AKI among general hospitalized patients in developing countries has been published. We developed a simple, real-time, interpretable AKI prediction model for general hospitalized patients from a large tertiary hospital in China, and validated it across five independent, geographically distinct, different tiered hospitals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2023
CompletedFirst Submitted
Initial submission to the registry
September 9, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedSeptember 19, 2024
September 1, 2024
1.7 years
September 9, 2024
September 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Predictive performance of the prediction model for Acute Kidney Injury
Evaluated using AUC
through study completion, varied from one to three years in different validation cohorts.
Eligibility Criteria
Adult patients admitted to five hospitals during the study period.
You may qualify if:
- Adult patients (18 years and older) admitted to five hospitals during the study period
You may not qualify if:
- Have less than 2 documented serum creatinine (Scr) measurements during hospitalization
- Being diagnosed with end-stage renal disease (ESRD)
- Maintained on dialysis or had an initial Scr greater than or equal to 4.0 mg/dL at admission
- Developed AKI prior to admission or within 24 hours after admission
- Length of stay shorter than 24 hours
- Underwent kidney transplantation or nephrectomy during hospitalization
- With all Scr measurements lower than or equal to 0.6 mg/dL from 90 days prior to admission until discharge.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Study Officials
- STUDY DIRECTOR
Li Yang
Peking University First Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 9, 2024
First Posted
September 19, 2024
Study Start
February 28, 2023
Primary Completion
October 30, 2024
Study Completion
December 30, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share